CausalSentinel

Protein Dossier — CPB2 (Carboxypeptidase B2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Alcohol intake frequency -0.0128 0.00446 0.00405 Wald ratio 1 cis NA
Glioma 0.129 0.0543 0.0177 Wald ratio 1 cis NA
Cancer code self-reported: malignant melanoma -0.0847 0.0373 0.023 Wald ratio 1 cis NA
Depressive symptoms -0.0106 0.00471 0.0244 Wald ratio 1 cis NA
Diagnoses - main ICD10: D12 Benign neoplasm of colon rectum anus and anal canal 0.054 0.0241 0.0253 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypertension -0.011 0.0052 0.0338 Wald ratio 1 cis NA
Non-cancer illness code self-reported: arthritis (nos) 0.0682 0.0325 0.0357 Wald ratio 1 cis NA
Large vessel disease -0.0907 0.0437 0.0379 Wald ratio 1 cis NA
Cardioembolic stroke 0.0817 0.0397 0.0395 Wald ratio 1 cis NA
Heel bone mineral density (BMD) T-score automated -0.00788 0.00391 0.0435 Wald ratio 1 cis NA
Height -0.00695 0.00365 0.057 Wald ratio 1 cis NA
Diagnoses - main ICD10: Z09 Follow-up examination after treatment for conditions other than malignant neoplasms 0.0442 0.0235 0.0596 Wald ratio 1 cis NA
…and 93 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3518_54_2 TAFI Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

126 association rows across 74 traits (121 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Succinate-semialdehyde dehydrogenase, mitochondrial levels 2e-2461 rs1926446 1 GCST90249659 no MR -> candidate analysis
FAS-associated death domain protein levels 1e-893 rs1926446 2 GCST90247545 no MR -> candidate analysis
Carboxypeptidase B2 levels 8e-839 rs7336360 4 GCST90246876 no MR -> candidate analysis
Melanoregulin levels 3e-749 rs7336360 1 GCST90248518 no MR -> candidate analysis
Uncharacterized protein KIAA2013 levels 2e-658 rs1926446 1 GCST90250135 no MR -> candidate analysis
Pirin levels 2e-436 rs1926446 2 GCST90249006 no MR -> candidate analysis
Uncharacterized protein KIAA2013 levels (KIAA2013.6538.90.3) 5e-232 rs532540191 1 GCST90243283 no MR -> candidate analysis
Apelin levels 9e-221 rs9534305 1 GCST90246537 no MR -> candidate analysis
LCP1 protein levels 3e-205 rs11618380 6 GCST90469748 no MR -> candidate analysis
Serum levels of protein CPB2 5e-194 rs9534313 1 GCST90088431 no MR -> candidate analysis
CPB2 protein levels 2e-177 rs17844025 15 GCST90468840 no MR -> candidate analysis
Serum levels of protein CALB1 5e-175 rs9534313 1 GCST90090908 no MR -> candidate analysis
…and 62 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 233 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
type 2 diabetes mellitus 0.288 common-variant locus no MR -> candidate analysis
ovarian neoplasm 0.079 common-variant locus no MR -> candidate analysis
deficiency anemia 0.06 common-variant locus no MR -> candidate analysis

Of the 3 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Carboxypeptidase B2)
gnomAD constraint pLI=6.2e-18, LOEUF=1.19 — LoF-tolerant
GWAS Catalog 100 unique SNPs / 202 rows
ClinVar 117 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance